Search

everythinglearnresearchcommunity

for

Search:↓

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.

Most skin changes during pregnancy go away after giving birth.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Women with PCOS have more emotional and body image issues than healthy women.

Acne is an important sign of androgen excess disorders in women.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Differentiating PCOS from NCAH helps improve diagnosis and treatment.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.